Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative splicing: combinatorial output from the genome.

Gavin C Roberts1, Christopher W J Smith

  • 1Cambridge Consultants Limited, Science Park, Milton Road, Cambridge, CB4 0DW, Cambridge, UK.

Current Opinion in Chemical Biology
|May 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An RBPMS-driven splicing regulatory axis including MBNL1, RBFOX2, and QK promotes smooth muscle cell contractile identity.

Nucleic acids research·2025
Same author

RNA binding protein with multiple splicing (RBPMS) promotes contractile phenotype splicing in human embryonic stem cell-derived vascular smooth muscle cells.

Cardiovascular research·2024
Same author

Cell-type specific regulator RBPMS switches alternative splicing via higher-order oligomerization and heterotypic interactions with other splicing regulators.

Nucleic acids research·2023
Same author

Phosphorylation of the smooth muscle master splicing regulator RBPMS regulates its splicing activity.

Nucleic acids research·2022
Same author

Myocardin regulates exon usage in smooth muscle cells through induction of splicing regulatory factors.

Cellular and molecular life sciences : CMLS·2022
Same author

Alternative splicing as a source of phenotypic diversity.

Nature reviews. Genetics·2022
Same journal

Stretching the limits: Decoding hidden biology with vibrational probes.

Current opinion in chemical biology·2026
Same journal

Function through shape: An overview of DNA G-quadruplexes in transcriptional regulation.

Current opinion in chemical biology·2026
Same journal

Advances in tools and technologies for multiplexed bioluminescence imaging.

Current opinion in chemical biology·2026
Same journal

High-resolution molecular mapping by expansion-coupled label-free and multimodal imaging.

Current opinion in chemical biology·2026
Same journal

Recent advances in glycoconjugate-based therapeutics.

Current opinion in chemical biology·2026
Same journal

Towards better red emitters for bioimaging: Innovations in rhodamine and cyanine chemistry.

Current opinion in chemical biology·2026
See all related articles

Alternative splicing significantly increases proteome complexity from a limited number of human genes. Analyzing the transcriptome requires advanced technologies to capture the diversity generated by alternative splicing.

Area of Science:

  • Genomics
  • Molecular Biology
  • Proteomics

Background:

  • The human genome has a surprisingly modest number of genes.
  • The expressed proteome exhibits much greater complexity than predicted by gene count alone.

Purpose of the Study:

  • To highlight the role of alternative splicing in explaining the discrepancy between gene number and proteomic complexity.
  • To emphasize the need for advanced transcriptome analysis technologies.

Main Methods:

  • Transcriptome analysis
  • Bioinformatic approaches to study gene expression and protein isoforms

Main Results:

  • Alternative splicing is a major contributor to proteomic diversity.
  • A significant proportion of human genes, potentially the majority, undergo alternative splicing.

Related Experiment Videos

  • Individual genes can produce thousands of protein isoforms through complex alternative splicing.

    • Conclusions:

    • Alternative splicing is a key mechanism driving proteomic complexity.
    • Future transcriptome analysis necessitates the development of high-throughput technologies capable of resolving alternative splicing events.